Methanol Poisoning – Market Outlook, Epidemiology, Competitive Landscape, and Market Forecast Report – 2021 To 2032
Methanol, also known as methyl alcohol, is commonly found in solvents, antifreeze, and fuel. Upon ingestion, methanol is rapidly absorbed and metabolized by alcohol dehydrogenase (ADH) in the liver, distributed throughout the body water with a volume distribution of approximately 0.77 L/kg, and eliminated as unchanged parent compounds. The clinical manifestations of methanol poisoning (MP) typically occur within 0.5-4 hours post-ingestion and may include symptoms such as gastrointestinal disturbances and central nervous system suppression. Following a latent period of 6-24 hours, depending on the absorbed dose, decompensated metabolic acidosis may occur, characterized by symptoms such as blurred vision and early or late blindness. The estimated least lethal dose of methanol for adults is approximately 10 mL. Complications associated with methanol toxicity include metabolic acidosis, permanent visual deficits, Parkinson-like disease, coma, respiratory and circulatory failure, complications related to dialysis, and death.
·
Treatment options for methanol toxicity
include supportive care, fomepizole, ethanol, and dialysis. Ethanol is used to
compete with methanol for metabolism in the body, preventing the formation of
toxic metabolites. Dialysis also is used to remove methanol from the
bloodstream.
Thelansis’s “Methanol Poisoning Market
Outlook, Epidemiology, Competitive
Landscape, and Market Forecast Report – 2021 To 2032" covers disease
overview, epidemiology, drug utilization, prescription share analysis,
competitive landscape, clinical practice, regulatory landscape, patient share,
market uptake, market forecast, and key market insights under the potential Methanol
Poisoning treatment modalities options for eight major markets (USA, Germany,
France, Italy, Spain, UK, Japan, and China).
KOLs insights
of Methanol Poisoning across 8 MM market from the centre of Excellence/ Public/
Private hospitals participated in the study. Insights around current treatment
landscape, epidemiology, clinical characteristics, future treatment paradigm,
and Unmet needs.
Methanol Poisoning Market Forecast Patient
Based Forecast Model (MS. Excel Based Automated Dashboard), which Data Inputs
with sourcing, Market Event, and Product Event, Country specific Forecast
Model, Market uptake and patient share uptake, Attribute Analysis, Analog
Analysis, Disease burden, and pricing scenario, Summary, and Insights.
Thelansis Competitive Intelligence (CI) practice
has been established based on a deep understanding of the pharma/biotech
business environment to provide an optimized support system to all levels of
the decision-making process. It enables business leaders in forward-thinking
and proactive decision-making. Thelansis supports scientific and commercial
teams in seamless CI support by creating an AI/ ML-based technology-driven
platform that manages the data flow from primary and secondary sources.
Comments
Post a Comment